Final-Program-ATS-2023-AP.vp

TUESDAY • MAY 23

289

occupational health fields, as well as PhD scientists, and those working in global health Objectives At the conclusion of this session, the participant will be able to: • raise awareness about the emerging epidemiologic and mechanistic evidence that suggests a causal relationship between air pollution exposures, tuberculosis development and worsened treatment outcomes • review the state of the science for air pollution exposure assessment approaches, technologies and optimal measurement strategies • explore translation of scientific discovery into actionable health preventative steps This session reviews the current epidemiologic and mechanistic knowledge on associations between exposures to air pollution, tobacco smoke and risk for tuberculosis, three eminent health challenges of global importance, and how exposure risks relate to social determinants of health. Addressing the need for continued research on exposure dose response relationships as well as for translation of findings into regulatory policies, the session also discusses pitfalls and state of the art of exposure assessments as well as the translation of scientific findings into advocacy for policy change. Chairing: C.M. North, MD, MPH, Boston, MA S. Schwander, MD, PhD, Piscataway, NJ 2:15 The Global State of Air Pollution and Tuberculosis: What Does the Epidemiology Show? S. Carroll, BSc, Montreal, Canada 2:30 The State of the Art for Characterizing Air Pollution Exposure Among People at Risk for Tuberculosis Q. Meng, PhD, Reno, NV 2:45 The Influence of Social Determinants of Health on Air Pollution Exposure and Tuberculosis Risk - Triple Trouble in Resource-Limited Settings L. Atuyambe, PhD, Kampala, Uganda 3:00 Mechanistic Evidence - Air Pollutant Effects on Immune Responses to Mycobacterium Tuberculosis: Is the Sum Greater Than the Parts? S. Sarkar, PhD, Piscataway, NJ 3:15 Vaping and Smoking - the “Other Air Pollutants” R.N. Van Zyl Smit, MBChB, PhD, ATSF, Cape Town, South Africa 3:30 So, Air Pollutants Are Making Tuberculosis Worse - Now What? Activism and Policy Change N. Mistry, MD, Mumbai, India

• increase underrepresented minorities in research and increase workforce needed to support patients impacted by SDOH • align SDOH related research proposals with NIH funding priorities for SDOH related initiatives Attendees will learn about cutting edge research on the impact of SDOH on respiratory health, including patients affected by SDOH in clinical trials, reducing workforce gaps that exacerbate the impact of SDOH on outcome, ATS advocacy activities targeting reduction in SDOH and NIH research priorities directed at mitigating the impact of SDOH on health outcomes. Chairing: F. Afolabi, MD, Dallas, TX S.C. Sweet, MD, PhD, Saint Louis, MO 2:15 Addressing SDOH Through Research and Workforce Development: The Time is NOW S.C. Sweet, MD, PhD, Saint Louis, MO 2:20 Cutting Edge Research: The Impact of SDOH on Respiratory Disease, Sleep, Critical Illness, and Recovery S. Jain, MD, New Haven, CT 2:35 Addressing Maslow’s Hierarchy: Integrating SDOH in Research T. Winders, MBA, Vienna, VA 2:50 The Workforce Meets SDOH I.L. Riley, MD, MPH, Durham, NC 3:05 Moving the SDOH Needle: Partnering with Patients and Other Organizations to Advocate for Policy Change E. Sward, BA, MA, Washington, DC 3:20 The Next Frontier: NIH Priorities and Resources to Address SDOH M. Freemer, MD, MPH, Bethesda, MD 3:35 Panel Discussion

TRANSLATIONAL SCIENTIFIC SYMPOSIUM CME Credits Available: 1.5

C90

DOUBLE TROUBLE: AIR POLLUTANTS AND TUBERCULOSIS

Assemblies on Environmental, Occupational and Population Health; Behavioral Science and Health Services Research; Pulmonary Infections and Tuberculosis; International Health Committee 2:15 PM - 3:45 PM Walter E. Washington Convention Center Room 202 A (Level 2) Target Audience Clinicians in pulmonary, infectious disease, environmental and

ATS 2023 • Washington, DC